Cargando…
Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs
This review summarizes the more recent evidence about epidemiology and risk factors for invasive fungal infections (IFI) in patients affected by Chronic Lymphocytic Leukemia (CLL), indolent Non Hodgkin Lymphoma (iNHL) and Multiple Myeloma (MM). Despite advances in the prognosis and treatment of hema...
Autores principales: | Facchinelli, Davide, Marchesini, Gessica, Nadali, Gianpaolo, Pagano, Livio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223569/ https://www.ncbi.nlm.nih.gov/pubmed/30416695 http://dx.doi.org/10.4084/MJHID.2018.063 |
Ejemplares similares
-
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study
por: Marchesini, Gessica, et al.
Publicado: (2020) -
Invasive Fungal Infections 2021
por: Xess, Immaculata, et al.
Publicado: (2022) -
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
por: Cattaneo, Chiara, et al.
Publicado: (2022) -
Invasive fungal infections in high-risk patients: report from TIMM-8 2017
por: Pagano, Livio, et al.
Publicado: (2018) -
Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice
por: Rambaldi, Benedetta, et al.
Publicado: (2017)